• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Oncology: International Journal of Cancer Research and Treatment >Progress in surgical treatment of hepatocellular carcinoma.
【24h】

Progress in surgical treatment of hepatocellular carcinoma.

机译：肝细胞癌的外科治疗进展。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Surgery for hepatocellular carcinoma has improved dramatically during the last two decades, and the improvement is mainly attributable to the development of intraoperative ultrasound-guided operative procedures such as Makuuchi's segmentectomy, introduction of the intermittent vascular occlusion technique, and establishment of the precise criteria for indications of various hepatectomy procedures. The use of preoperative portal vein embolization for inducing compensatory hypertrophy of remnant liver in the future has increased the safety and extended indications of hepatectomy for hepatocellular carcinoma. Operative mortality has fallen below 2% in the 1990s, with the 5-year survival rate reaching nearly 50% in a recent nationwide survey in Japan. More than 90% of hepatectomies at our institution are performed without red blood cell transfusions, and the mean hospital stay is shortened to approximately 23 days. Moreover, not a single case of operative death has been recorded since 1993.
机译：在过去的二十年中，肝细胞癌的手术有了显着改善，这主要归功于术中超声引导下的手术方法的发展，例如幕张氏节段切除术，间歇性血管闭塞技术的引入以及明确的适应症标准各种肝切除手术。将来使用术前门静脉栓塞术来诱导残余肝的代偿性肥大，已提高了肝癌肝切除术的安全性并扩大了适应症。在1990年代，手术死亡率已降至2％以下，最近一次全国范围的日本调查显示，其5年生存率接近50％。在我们机构中，有90％以上的肝切除手术是在没有红细胞输血的情况下进行的，并且平均住院时间缩短到大约23天。此外，自1993年以来，没有记录到任何手术死亡病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号